Compare COFS & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COFS | SGHT |
|---|---|---|
| Founded | 1898 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.9M | 489.7M |
| IPO Year | 1995 | 2021 |
| Metric | COFS | SGHT |
|---|---|---|
| Price | $34.24 | $9.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $37.00 | $10.17 |
| AVG Volume (30 Days) | 77.7K | ★ 313.7K |
| Earning Date | 11-10-2026 | 11-04-2026 |
| Dividend Yield | ★ 3.34% | N/A |
| EPS Growth | N/A | ★ 28.16 |
| EPS | ★ 1.74 | N/A |
| Revenue | ★ $227,624,000.00 | $77,363,000.00 |
| Revenue This Year | $8.11 | $16.75 |
| Revenue Next Year | $3.72 | $11.78 |
| P/E Ratio | $19.97 | ★ N/A |
| Revenue Growth | ★ 63.64 | N/A |
| 52 Week Low | $26.63 | $3.38 |
| 52 Week High | $35.00 | $9.71 |
| Indicator | COFS | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 57.52 | 59.30 |
| Support Level | $32.18 | $7.88 |
| Resistance Level | $34.93 | $9.71 |
| Average True Range (ATR) | 0.83 | 0.46 |
| MACD | 0.20 | 0.03 |
| Stochastic Oscillator | 70.94 | 81.92 |
ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.